# Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer

> **NCT00291707** · PHASE1 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** Pemetrexed
- **PROCEDURE:** radiation therapy

## Key facts

- **NCT ID:** NCT00291707
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-03
- **Final completion:** 2009-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291707, "Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00291707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*